Sort by
Refine Your Search
-
Category
-
Country
-
Field
-
of a postdoctoral position is to build up an academic track record that qualifies you for a position as assistant or associate professor. The position also offers additional skills that are to your
-
, pharmacy, biotechnology or bioengineering. Open to PhD students, PhD, Post-Doc and residents. Permanent positions such as Professors cannot apply. For the entire duration of the grant, applicants must be
-
physicians and associated health professionals. Fellows spend approximately 75 percent of their time in research and education and 25 percent in clinical activities. Faculty mentorship and individualized
-
, techniques or methods and ability to contribute to developing new ones Ability to assess resource requirements and use resources effectively Contribute to the planning and organising of the research programme
-
the Department of Inflammation and Ageing at the University of Birmingham. The successful candidate will work to deliver high level computational analysis of immune cell subsets in patients with cutaneous lupus
-
date September 26, 2025 Position Type Full Time - Trust Funded This position is part of the Post Doctoral Fellows Association and has an initial appointment of two years, with the possibility of renewal
-
of the research of Associate ProfessorDr Thomas Wälchli, MD-PhD, FMH neurosurgery is to understand how the brain vasculature is regulated during brain development, in the adult healthy brain, and in various
-
Call for Outstanding Global Talents & Postdoctoral Fellows of Institute of Energy, Peking University
or research institutions Strong teaching ability and research productivity 2) Assistant/Associate Research Professor Qualifications: Ph.D. degree Engaged in cutting-edge scientific research in the field
-
-dysfunction associated steatotic liver diseases). Our group is part of a vibrant scientific community at the TU Dresden and works closely with national and international partners within initiatives such as the
-
oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor prognosis, and this clinic